⌘K

Login Start Free

Home/Filings/4/0001140361-25-019053

4//SEC Filing

Ye Weiguo 4

Accession 0001140361-25-019053

CIK 0001124105other

View on SEC.gov Company Profile

Filed

May 13, 8:00 PM ET

Accepted

May 14, 8:21 PM ET

Size

6.6 KB

Accession

0001140361-25-019053

Insider Transaction Report

Form 4

Period: 2025-04-01

GYRE THERAPEUTICS, INC.GYRE

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2025-04-01$0.75/sh+50,000$37,500→ 700,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-04-01−50,000→ 965,115 total
Exercise: $0.75Exp: 2030-10-31→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]These options are vested in full.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

GYRE THERAPEUTICS, INC.

CIK 0001124105

Entity typeother

Related Parties

1

filerCIK 0001985496

Filing Metadata

Form type: 4
Filed: May 13, 8:00 PM ET
Accepted: May 14, 8:21 PM ET
Size: 6.6 KB

View on SEC.gov